Elmsford, NY, United States of America

Liqin Xie

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Surrozen Operating, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liqin Xie. Retrieved from https://idiyas.com/inventor/liqin-xie-3vmwliij

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liqin Xie: Innovator in Wnt Pathway Therapeutics

Introduction

Liqin Xie is a prominent inventor based in Elmsford, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods targeting the Wnt signaling pathway. Her innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Liqin Xie holds 1 patent for her invention titled "Wnt surrogate molecules and uses thereof." This patent provides Wnt pathway agonists and related compositions, which may be utilized in a variety of therapeutic methods for treating diseases. Her research focuses on harnessing the Wnt signaling pathway to develop effective treatments.

Career Highlights

Liqin Xie is currently associated with Surrozen Operating, Inc., a company dedicated to advancing therapeutic solutions through innovative research. Her role at Surrozen highlights her commitment to translating scientific discoveries into practical applications that can benefit patients.

Collaborations

Liqin collaborates with talented individuals in her field, including Yang Li and Tom Zhiye Yuan. These partnerships enhance her research efforts and contribute to the advancement of therapeutic innovations.

Conclusion

Liqin Xie's work exemplifies the spirit of innovation in biotechnology, particularly in the development of Wnt pathway therapeutics. Her contributions are paving the way for new treatment options that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…